DENOS présente sa plateforme de données DenosCare à Big Data Paris 2022
Le parcours patient personnalisé, de l’organisation à la gestion, nécessite la manipulation de données complexes et sensibles de natures et de sources très différentes. Ces
Bringing worldwide access to medical excellence and biotechnological innovations leading to personalized medicine
Bringing worldwide access to medical excellence,
biotechnological innovations and
personalized health pathway
Monitoring medical pathway for patients living in Europe and patients who wants to be treated in Europe.
Monitoring patients with chronic illness.
Providing expertise and consulting services to insurance companies.
Biotechs specialized
in oncology
Cooperation with innovative Medtechs
Hospital
engineering
Organization and monitoring of international patients pathways
Optimization of medical care through the best medico-economic approach
Cooperation with innovative Medtechs
Disease management of patients with chronic illness
Biotechs specialized
in oncology
Hospital
engineering
We are focused on three aspects of personalized medicine:
This spans across all geographical borders in order to maximize the opportunity by bringing together national healthcare systems.
We are focused on three aspects of personalized medicine:
This spans across all geographical borders in order to maximize the opportunity by bringing together national healthcare systems.
Provide states, insurance companies and patients with access to treatment, in France and worldwide. Control health cost and monitor patients with chronic illness.
Meet the growing needs of public and private hospital facilities by providing teams of experts, consultants and experienced nursing staff and health practitioners.
Develop in-vivo biomarkers for targeted therapies in oncology, in order to improve patients’ quality of life.
Le parcours patient personnalisé, de l’organisation à la gestion, nécessite la manipulation de données complexes et sensibles de natures et de sources très différentes. Ces
Malakoff Humanis, Swiss Life, DENOS et Owello regroupent leurs forces sur la mobilité internationale, pour l’accélération conjointe du développement et de la digitalisation en assurance
Parce que l’excellence d’un parcours de soins se détermine et se gère depuis le diagnostic et l’orientation du patient jusqu’au plus intime des rouages médicaux
« Cette opération représente une formidable reconnaissance pour les innovations développées par le groupe DENOS en médecine de précision, et notamment en imagerie moléculaire dédiée au
DENOS is pleased to announce that its biotech affiliate Zionexa, specialized in the development and commercialization of innovative biomarkers for diagnosis and targeted therapies in
Author : Jean-Louis Davet In France, inequal access to healthcare, due to national aspects, is a recurrent debate which remains important for the government and